SCHEMBL29596003

CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC

nearest known ligand 0.52

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	F2	P00734	2/20	0.43

▸	RXFP1	Q9HBX9	1/20	0.43

▸	ENPEP	Q07075	5/20	0.41

▸	GRIN2D	O15399	1/20	0.41

▸	GRIN3B	O60391	1/20	0.41

▸	GRIN1	Q05586	1/20	0.41

▸	GRIN2A	Q12879	1/20	0.41

▸	GRIN2B	Q13224	1/20	0.41

▸	GRIN2C	Q14957	1/20	0.41

▸	GRIN3A	Q8TCU5	1/20	0.41

▸	VIPR2	P41587	4/20	0.41

▸	VIPR1	P32241	2/20	0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30118952	0.94	RXFP1 (0.49)	RXFP1ENPEPVIPR2VIPR1
SCHEMBL6038377	0.91	NPY4R (0.40)	ENPEP
SCHEMBL29619336	0.91	CPB2 (0.45)	—
SCHEMBL31277463	0.91	ENPEP (0.46)	ENPEP
SCHEMBL30303032	0.91	ENPEP (0.46)	ENPEP
SCHEMBL6038374	0.91	NPY4R (0.40)	ENPEP
SCHEMBL30855541	0.91	NPY4R (0.40)	ENPEP
SCHEMBL31022845	0.90	ENPEP (0.50)	F2RXFP1ENPEPVIPR2VIPR1
SCHEMBL30229773	0.89	F2 (0.44)	F2ENPEP
SCHEMBL31514354	0.89	RXFP1 (0.46)	RXFP1VIPR2VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220175962-A1	GENE THERAPY COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE	SIO GENE THERAPIES INC (US)	2022-06-09	—	—	US	disclosed